Becton, Dickinson and Company

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-07-12 pm EDT			5-day change	1st Jan Change
229.1 ^USD	+1.85%		+0.59%	-6.04%

Jul. 10	Health Care Up in Anticipation of Deal Activity -- Health Care Roundup	DJ
Jul. 10	FDA Reports Supply Interruptions for Becton Dickinson BD BACTEC Culture Media Bottles	DJ

Declaration of Voting Results by Becton, Dickinson and Company

January 24, 2018 at 05:21 pm EST

On January 24, 2018, Becton, Dickinson and Company announced that at its annual general meeting of shareholders held on January 23, 2018, a shareholder proposal regarding an amendment to the Company's proxy access by-law was not approved.

Latest news about Becton, Dickinson and Company

Health Care Up in Anticipation of Deal Activity -- Health Care Roundup	Jul. 10	DJ
FDA Reports Supply Interruptions for Becton Dickinson BD BACTEC Culture Media Bottles	Jul. 10	DJ
US FDA flags shortage of Becton Dickinson's blood test tubes	Jul. 10	RE
Becton, Dickinson Says it Exceeded 2023 Emissions Reduction Targets	Jul. 10	MT
Citigroup Adjusts Price Target on Becton, Dickinson to $255 From $260	Jul. 10	MT
Goldman Sachs Adjusts Price Target on Becton, Dickinson to $262 From $274	Jul. 10	MT
Evercore ISI Adjusts Price Target on Becton, Dickinson to $285 From $290, Maintains Outperform Rating	Jul. 02	MT
BD (Becton, Dickinson and Company) Announces the Commercial Launch of a New Single-Cell Research Tool	Jun. 26	CI
Tandem Diabetes Care, Inc. Appoints Jean-Claude Kyrillos as Executive Vice President and Chief Operating Officer, Effective June 21, 2024	Jun. 20	CI
Evercore ISI Raises Becton, Dickinson and Company's Price Target to $290 From $282	Jun. 14	MT
Sector Update: Health Care Stocks Steady Premarket Monday	Jun. 03	MT
Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash	Jun. 03	DJ
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	Jun. 03	MT
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	Jun. 03	RE
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion	Jun. 03	MT
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.	Jun. 02	CI
DBS Bank Adjusts Price Target on Becton, Dickinson to $285 From $300	May. 15	MT
Transcript : Becton, Dickinson and Company Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM	May. 14
Exclusive-Biden to put tariffs on China medical supplies - sources	May. 10	RE
Barclays Adjusts Price Target on Becton, Dickinson to $312 From $305, Keeps Overweight Rating	May. 06	MT
TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $260 From $271	May. 03	MT
Tranche Update on Becton, Dickinson and Company's Equity Buyback Plan announced on November 4, 2021.	May. 02	CI
Evercore ISI Raises Becton, Dickinson and Company Price Target to $282 From $280	May. 02	MT
Sector Update: Health Care Stocks Mixed Premarket Thursday	May. 02	MT
Sector Update: Health Care	May. 02	MT

Chart Becton, Dickinson and Company

Duration

Period

More charts

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-01 - Q3 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Becton, Dickinson and Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

229.1 USD

Average target price

277.8 USD

Spread / Average Target

+21.26%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BECTON, DICKINSON AND COMPANY	-6.04%	66.21B
ABBOTT LABORATORIES	-5.31%	181B
MEDTRONIC PLC	-5.38%	99.95B
HOYA CORPORATION	+16.45%	45.4B
DEXCOM, INC.	-8.08%	45.36B
CENCORA, INC.	+8.38%	43.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+12.06%	29.03B
TERUMO CORPORATION	+17.98%	25.64B
WEST PHARMACEUTICAL SERVICES, INC.	-8.28%	23.53B
ZIMMER BIOMET HOLDINGS, INC.	-10.69%	22.36B

Other Medical Equipment, Supplies & Distribution